Potassium%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to treat and prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment of hypokalemia. * Prevention of hypokalemia, particularly in patients receiving diuretics or other medications that deplete potassium. ## Adult Dosing * **Oral:** * **Treatment of Hypokalemia:** Typically 20-100 mEq per day, divided into 1-4 doses. Doses may be higher in severe hypokalemia but should not exceed 20 mEq per dose or 200 mEq per 24 hours. * **Prevention of Hypokalemia:** Typically 20-40 mEq per day, divided into 1-2 doses. * **Intravenous (IV):** * **Treatment of Hypokalemia:** * Mild to moderate hypokalemia (serum potassium 2.5-3.5 mEq/L): 20-40 mEq IV, infused over 2-4 hours. * Severe hypokalemia (serum potassium <2.5 mEq/L): 40 mEq IV, infused over 1-2 hours. * Higher doses may be necessary but require careful ECG monitoring and may be limited by maximum infusion rates. * **Maximum Infusion Rate:** Generally, do not exceed 10-20 mEq/hour for peripheral IV administration. Higher rates (up to 40 mEq/hour) may be used in critical hypokalemia with central venous access and continuous ECG monitoring. * **Maximum Concentration:** Peripheral IV: typically 40 mEq/L. Central venous: up to 100 mEq/L may be used. ## Pediatric Dosing * **Oral:** * **Treatment of Hypokalemia:** 2-5 mEq/kg/day, divided into 2-4 doses, not to exceed adult maximums. * **Prevention of Hypokalemia:** 1-2 mEq/kg/day, divided into 1-2 doses. * **Intravenous (IV):** * **Treatment of Hypokalemia:** 0.5-1 mEq/kg/dose, infused over 1-3 hours. * **Maximum Infusion Rate:** Generally, do not exceed 0.3-0.5 mEq/kg/hour. Higher rates (up to 1 mEq/kg/hour) may be used in severe hypokalemia with continuous ECG monitoring. * **Maximum Dose:** 40 mEq per dose. * **Maximum Concentration:** Typically 40 mEq/L. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Reduce dose and monitor serum potassium closely due to risk of hyperkalemia. * **Adrenal Insufficiency:** Monitor potassium levels closely. ## Contraindications * Hyperkalemia. * Conditions associated with significant potassium retention (e.g., untreated Addison's disease, severe renal impairment, anuria, oliguria). * Gastrointestinal obstruction or delayed gastric emptying (oral formulations). ## Adverse Effects * **Common:** Nausea, vomiting, abdominal pain, diarrhea (oral). * **Serious:** * **Hyperkalemia:** Symptoms include weakness, fatigue, paresthesias, arrhythmias, cardiac arrest. This is the most significant risk, especially with rapid IV infusion, in renal impairment, or with concomitant potassium-sparing drugs. * **IV Administration:** Phlebitis, venous irritation, pain at infusion site. Rapid infusion can cause cardiac arrhythmias and cardiac arrest. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene), ACE inhibitors, ARBs, NSAIDs, certain immunosuppressants (e.g., cyclosporine, tacrolimus):** Increased risk of hyperkalemia. * **Digitalis glycosides:** Hyperkalemia can increase digitalis toxicity; hypokalemia can increase digitalis toxicity. Maintain potassium within the normal range. * **Neuromuscular blocking agents:** Potassium levels can affect neuromuscular blockade. ## Monitoring * **Serum potassium:** Monitor frequently, especially during IV therapy, with dose adjustments, and in patients with renal impairment. * **Renal function (BUN, creatinine):** Assess baseline and monitor periodically. * **ECG:** Particularly important for IV infusions of concentrated potassium or rapid infusions, and in patients with pre-existing cardiac conditions or severe hypokalemia. * **Signs and symptoms of hypokalemia and hyperkalemia.** ## Clinical Pearls * Oral potassium chloride should be administered with food or a meal and a full glass of water to minimize gastrointestinal irritation. * Dilute IV potassium chloride appropriately before administration. * Never administer IV potassium chloride as a bolus injection; it must be infused. * Consider the total daily potassium intake from all sources, including diet and IV fluids. * Use extended-release oral formulations to improve gastrointestinal tolerance. * Always verify the prescribed potassium dose and infusion rate against local institutional protocols, especially for IV administration in critical situations. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for definitive guidance.